Literature DB >> 22932985

Predictors of organ damage in systemic lupus erythematosus: the Hopkins Lupus Cohort.

Michelle Petri1, Sneha Purvey, Hong Fang, Laurence S Magder.   

Abstract

OBJECTIVE: The Systemic Lupus International Collaborating Clinics/American College of Rheumatology (ACR) Damage Index (SDI) is the accepted measure of permanent organ damage in systemic lupus erythematosus (SLE). We analyzed data from a large SLE cohort to identify variables associated with rates of damage accrual as measured by the SDI.
METHODS: The study included 2,054 SLE patients (92% female, 56% white, and 37% African American) with a mean age at diagnosis of 33 years. The SDI score was calculated retrospectively at the time of cohort entry and prospectively during followup. The relationships between time-invariant patient characteristics and rates of damage accrual were assessed based on the damage score at the last available followup visit. The relationships between time-varying patient characteristics and damage accrual were assessed based on the timing of damage accrual during cohort participation.
RESULTS: Overall, the SDI score increased at a rate of 0.13 per year. Higher rates of damage were observed for those who were older, male, or African American, had a lower income or education level, were hypertensive, were positive for lupus anticoagulant, or had proteinuria. During followup, the risk of damage was higher for those who were older, had more disease activity, had low complement levels, were positive for anti-double-stranded DNA, satisfied more ACR criteria for SLE, or were receiving corticosteroids. Lower risk was observed among patients receiving hydroxychloroquine. After adjustment for other variables, age, hypertension, and corticosteroid use emerged as the most important predictors of damage accrual.
CONCLUSION: Our findings indicate that rates of damage vary in demographic subgroups, but much variation appears to be explained by hypertension and corticosteroid use. These data clearly point to the need for tight control of disease activity without reliance on corticosteroids.
Copyright © 2012 by the American College of Rheumatology.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22932985      PMCID: PMC3510359          DOI: 10.1002/art.34672

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  15 in total

1.  Measurement of damage in 210 Mexican patients with systemic lupus erythematosus: relationship with disease duration.

Authors:  A Zonana-Nacach; A Camargo-Coronel; P Yáñez; M de Lourdes Sánchez; F J Jímenez-Balderas; J Aceves-Avila; P Martínez-Osuna; J Fuentes; F Medina; A Fraga
Journal:  Lupus       Date:  1998       Impact factor: 2.911

2.  SLICC/ACR Damage Index in Afro-Caribbean patients with systemic lupus erythematosus: changes in and relationship to disease activity, corticosteroid therapy, and prognosis.

Authors:  J C Nossent
Journal:  J Rheumatol       Date:  1998-04       Impact factor: 4.666

3.  The reliability of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index in patients with systemic lupus erythematosus.

Authors:  D D Gladman; M B Urowitz; C H Goldsmith; P Fortin; E Ginzler; C Gordon; J G Hanly; D A Isenberg; K Kalunian; O Nived; M Petri; J Sanchez-Guerrero; M Snaith; G Sturfelt
Journal:  Arthritis Rheum       Date:  1997-05

4.  The relationship of socioeconomic status, race, and modifiable risk factors to outcomes in patients with systemic lupus erythematosus.

Authors:  E W Karlson; L H Daltroy; R A Lew; E A Wright; A J Partridge; A H Fossel; W N Roberts; S H Stern; K V Straaton; M C Wacholtz; A F Kavanaugh; J M Grosflam; M H Liang
Journal:  Arthritis Rheum       Date:  1997-01

5.  Damage in systemic lupus erythematosus and its association with corticosteroids.

Authors:  A Zonana-Nacach; S G Barr; L S Magder; M Petri
Journal:  Arthritis Rheum       Date:  2000-08

6.  Association of damage with autoantibody profile, age, race, sex and disease duration in systemic lupus erythematosus.

Authors:  C-S Yee; H Hussein; J Skan; S Bowman; D Situnayake; C Gordon
Journal:  Rheumatology (Oxford)       Date:  2003-02       Impact factor: 7.580

7.  Systemic lupus erythematosus in three ethnic groups. IX. Differences in damage accrual.

Authors:  G S Alarcón; G McGwin; A A Bartolucci; J Roseman; J Lisse; B J Fessler; H M Bastian; A W Friedman; J D Reveille
Journal:  Arthritis Rheum       Date:  2001-12

8.  Mortality in systemic lupus erythematosus: the bimodal pattern revisited.

Authors:  L A Rubin; M B Urowitz; D D Gladman
Journal:  Q J Med       Date:  1985-04

9.  Systemic lupus erythematosus in three ethnic groups. XX. Damage as a predictor of further damage.

Authors:  G S Alarcón; J M Roseman; G McGwin; A Uribe; H M Bastian; B J Fessler; B A Baethge; A W Friedman; J D Reveille
Journal:  Rheumatology (Oxford)       Date:  2003-08-15       Impact factor: 7.580

Review 10.  The development and initial validation of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index for systemic lupus erythematosus.

Authors:  D Gladman; E Ginzler; C Goldsmith; P Fortin; M Liang; M Urowitz; P Bacon; S Bombardieri; J Hanly; E Hay; D Isenberg; J Jones; K Kalunian; P Maddison; O Nived; M Petri; M Richter; J Sanchez-Guerrero; M Snaith; G Sturfelt; D Symmons; A Zoma
Journal:  Arthritis Rheum       Date:  1996-03
View more
  67 in total

1.  Predictors of damage accrual in systemic lupus erythematosus: a longitudinal observational study with focus on neuropsychological factors and anti-neuronal antibodies.

Authors:  Milena Mimica; Ignacio Barra; Rocío Ormeño; Patricia Flores; Jorge Calderón; Oslando Padilla; Marcela Bravo-Zehnder; Alfonso González; Loreto Massardo
Journal:  Clin Rheumatol       Date:  2019-07-31       Impact factor: 2.980

2.  Connective tissue diseases: Remission in SLE - are we there yet?

Authors:  Eric F Morand
Journal:  Nat Rev Rheumatol       Date:  2016-10-27       Impact factor: 20.543

Review 3.  Why targeted therapies are necessary for systemic lupus erythematosus.

Authors:  L Durcan; M Petri
Journal:  Lupus       Date:  2016-09       Impact factor: 2.911

4.  Dissecting the damage in Northern Greek patients with childhood-onset systemic lupus erythematosus: a retrospective cohort study.

Authors:  Artemis Koutsonikoli; Maria Trachana; Anna-Bettina Heidich; Vasiliki Galanopoulou; Polyxeni Pratsidou-Gertsi; Alexandros Garyphallos
Journal:  Rheumatol Int       Date:  2015-01-14       Impact factor: 2.631

5.  Clinical manifestations and survival among adults with (SLE) according to age at diagnosis.

Authors:  J F Merola; B Bermas; B Lu; E W Karlson; E Massarotti; P H Schur; K H Costenbader
Journal:  Lupus       Date:  2014-03-07       Impact factor: 2.911

Review 6.  Why are kids with lupus at an increased risk of cardiovascular disease?

Authors:  Catherine Quinlan; Stephen D Marks; Kjell Tullus
Journal:  Pediatr Nephrol       Date:  2015-09-23       Impact factor: 3.714

7.  Organ damage in patients with incomplete lupus syndromes: from a Chinese academic center.

Authors:  Zhen Chen; Meng-Tao Li; Dong Xu; Xiao-Mei Leng; Qian Wang; Xin-Ping Tian; Shang-Zhu Zhang; Yan Zhao; Xiao-Feng Zeng
Journal:  Clin Rheumatol       Date:  2015-02-18       Impact factor: 2.980

8.  Comparison of Remission and Lupus Low Disease Activity State in Damage Prevention in a United States Systemic Lupus Erythematosus Cohort.

Authors:  Michelle Petri; Laurence S Magder
Journal:  Arthritis Rheumatol       Date:  2018-11       Impact factor: 10.995

Review 9.  Update on Antiphospholipid Syndrome: Ten Topics in 2017.

Authors:  Ilaria Cavazzana; Laura Andreoli; Maarteen Limper; Franco Franceschini; Angela Tincani
Journal:  Curr Rheumatol Rep       Date:  2018-03-15       Impact factor: 4.592

10.  Organ damage in high-risk patients with systemic and incomplete lupus syndromes.

Authors:  Nancy J Olsen; Maha Yousif; Azza Mutwally; Melinda Cory; Nada Elmagboul; David R Karp
Journal:  Rheumatol Int       Date:  2013-05-30       Impact factor: 2.631

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.